Ultrasonographic and pathological endometrial findings in asymptomatic postmenopausal women taking antihypertensive drugs

Maturitas

Volumn 46, Issue 1, 2003, Pages 27-32

  Martínez Rubio, Maria Pilar ^a   Alcázar, Juan Luis ^b  

^a Instituto de Investigación Sanitaria de Navarra   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Arterial hypertension; Endometrium; Postmenopause; Transvaginal sonography

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIAL DISEASE; EVALUATION; FEMALE; HUMAN; HYPERTENSION; HYSTEROSCOPY; INCIDENCE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PROSPECTIVE STUDY; TRANSVAGINAL ECHOGRAPHY;

STAPHYLOCOCCUS PHAGE 187;

EID: 0041878901     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(03)00160-9     Document Type: Article

References (18)

1. Taipale P., Tarjanne H., Neinonen N.M. The diagnostic value of vaginal sonography in the diagnosis of endometrial malignancy in women with peri- and postmenopausal bleeding. Acta Obstet. Gynecol. Scand. 73:1994;819-823.
2. Karlsson B., Granberg S., Wikland M., et al. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding: a Nordic multicenter study. Am. J. Obstet. Gynecol. 172:1995;1488-1493.
3. Vuento M.H., Pirhonen J.P., Makinen J.I., et al. Screening for endometrial cancer in asymptomatic postmenopausal women with conventional and color Doppler sonography. Br. J. Obstet. Gynecol. 106:1999;14-20.
4. Reuss M.A., Kolton S., Tharakan T. Transvaginal ultrasonography in gynecologic office practice: assessment in 663 premenopausal women. Am. J. Obstet. Gynecol. 175:1996;1189-1194.
5. Smith-Bindman R., Kerlikowske K., Feldstein V.A., et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. J. Am. Med. Assoc. 280:1998;1510-1517.
6. Affinito P., Palombas A., Pellicano M., et al. Ultrasonography measurement of endometrial thickness during hormonal replacement therapy in postmenopausal women. Ultrasound Obstet. Gynecol. 11:1998;343-346.
7. Tesoro M.R., Borgida A.F., MacLaurin N.A., et al. Transvaginal endometrial sonography in postmenopausal women taking tamoxifen. Obstet. Gynecol. 93:1999;363-366.
8. Gull B., Karlsson B., Milsom I., et al. Transvaginal sonography of the endometrium in a representative sample of postmenopausal women. Ultrasound Obstet. Gynecol. 7:1996;332-337.
9. Appelman Z., Ben-Arie A., Katz Z., et al. Endometrial pathology in hypertensive women. Ultrasound Obstet. Gynecol. 11:1998;178-379.
10. Pardo J., Aschkenazi S., Kaplan B., et al. Abnormal sonographic endometrial findings in asymptomatic postmenopausal women: possible role of antihypertensive drugs. Menopause. 5:1998;223-225.
11. Alcázar J.L. Endometrial sonographic findings in asymptomatic hypertensive postmenopausal women. J. Clin. Ultrasound. 289:2000;175-178.
12. Bornstein J., Auslender R., Goldstein S., et al. Increased endometrial thickness in women with hypertension. Am. J. Obstet. Gynecol. 183:2000;583-587.
13. Andolf E., Dahlander K., Aspenberg P. Ultrasonic thickness of endometrium correlated to body weight in asymptomatic postmenopausal women. Obstet. Gynecol. 82:1993;936-940.
14. Staessen J., Bulpitt C., Fagard M., et al. The influence of menopause on blood pressure. J. Hum. Hypertens. 3:1989;427-433.
15. Purdie D.M., Green A.C. Epidemiology of endometrial cancer. Best Pract. Res. Clin. Obstet. Gynaecol. 15:2001;341-354.
16. Gull B., Karlsson K., Milsom I., Granberg S. Factors associated with endometrial thickness and uterine size in a random sample of postmenopausal women. Am. J. Obstet. Gynecol. 185:2001;386-391.
17. Koss L.G., Schreiber K., Oberlander S.G., Moussouris H.F., Lesser M. Detection of endometrial carcinoma and hyperplasia in asymptomatic women. Obstet. Gynecol. 64:1984;1-11.
18. Gerber B., Krause A., Müller H., et al. Ultrasonographic detection of asymptomatic endometrial cancer in postmenopausal patients offers no prognostic advantage over symptomatic disease discovered by uterine bleeding. Eur. J. Cancer. 37:2001;64-71.